Yep, this is why MSB should continue with a Covid trial, we are not that far away from a EUA. I think MSB is not going to shelve this and another partner or sponsor is about to step in for funding.
Novartis walked due to "sub par data"., page-134
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.42 |
Change
-0.025(1.74%) |
Mkt cap ! $1.627B | |||
| Open | High | Low | Value | Volume |
| $1.44 | $1.46 | $1.40 | $1.449M | 1.018M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 25 | 9342 | $1.41 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.42 | 15382 | 10 |
View Market Depth
| Last trade - 13.00pm 15/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |